Editorials:

J Luderer, AA Piergies, D Jorkasky, A Sedman, S Reele, J Froehlich, J Cavanaugh, and GL Steinman

Clinical pharmacology and first-time-in-man studies: the FDA levels the playing field
J Clin Pharmacol 1996 36: 187. [PDF]  

Articles:

M Gibaldi and W Kradjan

Treating elevated cholesterol levels: the great Satan in perspective
J Clin Pharmacol 1996 36: 189. [Abstract] [PDF]  

TJ Cleophas and HJ van Lier

Crossover trials with a binary response: a powerful method despite the carryover effect
J Clin Pharmacol 1996 36: 198. [Abstract] [PDF]  

K Sunaga, T Sudoh, and A Fujimura

Lack of diurnal variation in glomerular filtration rates in the elderly
J Clin Pharmacol 1996 36: 203. [Abstract] [PDF]  

WD Figg, GE Dukes, JF Pritchard, DJ Hermann, HR Lesesne, SW Carson, SS Songer, Powell, JR, and LJ Hak

Pharmacokinetics of ondansetron in patients with hepatic insufficiency
J Clin Pharmacol 1996 36: 206. [Abstract] [PDF]  

A Patat, F le Coz, C Dubruc, JM Gandon, G Durrieu, I Cimarosti, S Jezequel, O Curet, I Zieleniuk, H Allain, and P Rosenzweig

Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers
J Clin Pharmacol 1996 36: 216. [Abstract] [PDF]  

JX Sun, B Walter, EP Sandefer, RC Page, GA Digenis, UY Ryo, A Cipriano, WM Maniara, ML Powell, and K Chan

Explaining variable absorption of a hypolipidemic agent (CGP 43371) in healthy subjects by gamma scintigraphy and pharmacokinetics
J Clin Pharmacol 1996 36: 230. [Abstract] [PDF]  

J Lavelle, S Follansbee, CB Trapnell, WC Buhles, KG Griffy, D Jung, A Dorr, and J Connor

Effect of food on the relative bioavailability of oral ganciclovir
J Clin Pharmacol 1996 36: 238. [Abstract] [PDF]  

DM Gibson, NJ Bron, A Richens, NJ Hounslow, AJ Sedman, and LR Whitfield

Effect of age and gender on pharmacokinetics of atorvastatin in humans
J Clin Pharmacol 1996 36: 242. [Abstract] [PDF]  

LD Carlton, JH Patterson, CN Mattson, and VD Schmith

The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure
J Clin Pharmacol 1996 36: 247. [Abstract] [PDF]  

LD Carlton, JH Patterson, CN Mattson, and VD Schmith

The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure
J Clin Pharmacol 1996 36: 257. [Abstract] [PDF]  

WG Kramer, WB Smith, J Ferguson, T Serpas, Grant AG, 3rd, PK Black, and DC Brater

Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure
J Clin Pharmacol 1996 36: 265. [Abstract] [PDF]  

K Harada, M Ohmori, A Fujimura, and K Ohashi

No evidence of a direct venodilatory effect of furosemide in healthy human subjects
J Clin Pharmacol 1996 36: 271. [Abstract] [PDF]  

K Abbott, A Smith, and GL Bakris

Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes
J Clin Pharmacol 1996 36: 274. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.